Ovarian cancer treatment depends on several factors, including the type and stage of cancer, tumor characteristics, overall health, and previous treatments. Current approaches may include surgery, chemotherapy, targeted therapy, hormone therapy, and, in selected situations, immunotherapy or clinical trials. Treatment plans are often developed by a multidisciplinary medical team and may change based on how the cancer responds. Understanding the purpose of each therapy, possible side effects, follow up care, and ongoing monitoring can help patients and families prepare for the treatment process and discuss appropriate options with their healthcare professionals.
Ovarian cancer treatment has advanced through improvements in surgical techniques, medicines, genetic testing, and personalized treatment planning. The approach used for each person may differ depending on whether the cancer is newly diagnosed, has returned after treatment, or has spread to other areas.
Current Therapies Used for Ovarian Cancer
Treatment commonly begins with an evaluation of the cancer type and stage. Doctors may also consider genetic changes, including BRCA mutations and other biomarkers, because these findings can influence treatment decisions.
- Surgery: Surgery may be used to remove the ovaries, fallopian tubes, uterus, nearby tissues, and visible areas of cancer when appropriate. The extent of surgery depends on the location and spread of the disease.
- Chemotherapy: Chemotherapy is frequently used after surgery or, in some cases, before surgery. Platinum based medicines are commonly included in treatment for several forms of ovarian cancer.
- Targeted therapy: Some targeted medicines focus on specific processes that cancer cells use to grow or repair damaged DNA. PARP inhibitors are one example and may be considered for certain patients based on genetic findings and treatment response.
- Hormone therapy: Certain types of ovarian cancer may respond to treatments that affect hormones. This approach may be considered depending on the specific tumor type.
- Immunotherapy: Immunotherapy is not suitable for every type of ovarian cancer, but it may be considered in selected cases based on specific tumor features.
What Patients May Expect During Treatment
The treatment experience can vary considerably. Some people receive a combination of surgery and medication, while others may need additional treatment if the cancer returns. Regular appointments and tests are often used to monitor treatment response and overall health.
- Treatment planning: Doctors may perform imaging tests, blood tests, pathology reviews, and genetic or biomarker testing before finalizing a treatment strategy.
- Possible side effects: Surgery and medicines can cause side effects such as fatigue, nausea, changes in appetite, bowel changes, pain, nerve symptoms, or changes in blood cell counts. The effects experienced depend on the specific treatment.
- Follow up care: After treatment, regular follow up visits may include physical examinations, discussions about symptoms, and selected tests or scans when medically appropriate.
- Supportive care: Nutrition guidance, pain management, emotional support, and other supportive services may be included as part of overall cancer care.
- Clinical trials: Some patients may discuss clinical trials that study new medicines, treatment combinations, or approaches to ovarian cancer management.
Ovarian cancer treatment is increasingly guided by individual factors, including cancer subtype, stage, genetic findings, and previous response to therapy. Open communication with a qualified oncology team can help patients understand the purpose of treatment, possible effects, monitoring requirements, and the options that may be relevant throughout their care.